Results 111 to 120 of about 15,828 (290)

Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes [PDF]

, 2003
BACKGROUND: Polymorphonuclear neutrophils (PMNs) have gained attention as critical mediators of acute coronary syndromes (ACS). Myeloperoxidase (MPO), a hemoprotein abundantly expressed by PMNs and secreted during activation, possesses potent ...
Eiserich, J.P. (Jason), Hamm, C.W. (Christian), Heeschen, C. (Christopher), Meinertz, T. (Thomas), Munzel, T. (Thomas), Simoons, M.L. (Maarten), Zeiher, A.M. (Andreas)   +6 more
core   +1 more source

Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban

Кардиоваскулярная терапия и профилактика, 2008
The review presents literature data on the key role of platelet aggregation (PA) for intracoronary thrombogenesis in various acute coronary syndromes (ACS) and percutaneous coronary interventions (PCI).
T. A. Batyraliev, D. V. Preobrazhensky, D. V. Fetzer, B. A. Sidorenko, S. A. Pataraya   +4 more
doaj  

Intracranial bleeding mimicking an extensive acute myocardial infarction with reversible apical ballooning and systolic left ventricular dysfunction. A case report

Monaldi Archives for Chest Disease, 2016
A novel syndrome with transient asynergy of the apical segments of the left ventricle, also known as tako-tsubo cardiomyopathy, has been recently described and presents characteristics and effects similar to acute myocardial infarction.
Antonio D’Aloia, Enrico Vizzardi, Pompilio Faggiano, Claudia Fiorina, Livio Dei Cas   +4 more
doaj   +1 more source

Administration of Abciximab During Percutaneous Coronary Intervention Reduces Both Ex Vivo Platelet Thrombus Formation and Fibrin Deposition [PDF]

, 1998
George Dangas, Juan J. Badimón, Barry S. Coller, John T. Fallon, Sanjeev Sharma, Richard M. Hayes, Perwaiz Meraj, John A. Ambrose, Jonathan D. Marmur   +8 more
openalex   +1 more source

Immediate Spastic Hemiplegia following Coil Embolization of an Anterior Communicating Artery Aneurysm

Case Reports in Neurology, 2011
Background: Acute ischemia typically results in a flaccid paralysis. An immediate spastic hemiparesis following ischemia has rarely been reported.
Jordan Dubow, Lewis Z. Leng, Y.Pierre Gobin   +2 more
doaj   +1 more source

Emergency coronary bypass grafting for failed percutaneous coronary artery stenting: increased costs and platelet transfusion requirements after the use of abciximab [PDF]

, 1998
John M. Alvarez
openalex   +1 more source

Investigation of interaction of human platelet membrane components with anticoagulant drugs Abciximab and Eptifibatide.

Folia Histochemica et Cytobiologica, 2011
Abciximab (Abci) and eptifibatide (Epti) are antiaggregate drugs which may reduce thrombotic complications in acute coronary syndromes. The aim of this work was the investigation of the interaction between the phospholipid-GPIIb/IIIa glycoprotein complex
Anna Sankiewicz, Ewa Gorodkiewicz, Zbigniew A Figaszewski   +2 more
doaj   +1 more source

Prophylaxis of Experimental Endocarditis With Antiplatelet and Antithrombin Agents: A Role for Long-term Prevention of Infective Endocarditis in Humans? [PDF]

, 2017
Background. Infective endocarditis (IE) mostly occurs after spontaneous low-grade bacteremia. Thus, IE cannot be prevented by circumstantial antibiotic prophylaxis.
Chaouch, Aziz, Entenza, José Manuel, Giddey, Marlyse, Moreillon, Philippe, Que, Yok-Ai, Rousson, Valentin, Veloso, Tiago Rafael, Vouillamoz, Jacques   +7 more
core  

Terapias emergentes: inhibidores de glicoproteína IIB/IIIA en ataque cerebrovascular agudo

Acta Neurológica Colombiana, 2010
El ataque cerebrovascular (ACV) es una causa común de morbilidad y mortalidad en el mundo. La terapia trom- bolítica con (r-TPA), es la única terapia aprobada para el tratamiento del ACV y esta terapia solo se logra aplicar en el 2 % de los pacientes ...
Juliana Coral Casas
doaj   +2 more sources

Intracoronary reopro during percutaneous coronary intervention in acute and stable patient can influence stent thrombosis formation (IRPASST) study

Heart Views, 2013
Background: In patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty, abciximab reduces major adverse cardiac events (MACE). Most clinical trials have studied mainly intravenous administration.
Mohammed Balghith, Ali Al-Ghamdi, El harif Zain, Ahmed Al-Saileek   +3 more
doaj